A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2.

Type I and type II keratins form the heteropolymeric intermediate filament cytoskeleton, which is the main stress-bearing structure within epithelial cells. Pachyonychia congenita (PC) is a group of autosomal dominant disorders whose most prominent phenotype is hypertrophic nail dystrophy accompanied by other features of ectodermal dysplasia. It has been shown previously that mutations in either K16 or K6a, which form a keratin expression pair, produce the PC-1 variant (MIM 184510). Mutations in K17 alone, an unpaired accessory keratin, result in the PC-2 phenotype (MIM 184500). Here, we describe a family with PC-2 in which the K17 locus on 17q was excluded and linkage to the type II keratin locus on 12q was obtained (Z max 3.31 at straight theta = 0). Mutation analysis of candidate keratins revealed the first reported missense mutation in K6b, implying that this keratin is the previously unknown expression partner of K17, analogous to the K6a/K16 pair. Co-expression of these genes was confirmed by in situ hybridization and immunohistochemical staining. These results reveal the hitherto unknown role of the K6b isoform in epithelial biology, as well as genetic heterogeneity in PC-2.

[1]  Munro,et al.  Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2 , 1998, The British journal of dermatology.

[2]  H. Winter,et al.  A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix , 1997, Human Genetics.

[3]  H. Winter,et al.  Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix , 1997, Nature Genetics.

[4]  Jonathan E. Moore,et al.  Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy , 1997, Nature Genetics.

[5]  E. Lane,et al.  Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. , 1997, The Journal of investigative dermatology.

[6]  M. Omary,et al.  Mutation of human keratin 18 in association with cryptogenic cirrhosis. , 1997, The Journal of clinical investigation.

[7]  W. McLean,et al.  Human keratin diseases: , 1996, Experimental dermatology.

[8]  E. Fuchs,et al.  The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Weissenbach,et al.  Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. , 1996, Archives of dermatology.

[10]  D. Kelsell,et al.  Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. , 1995, Human molecular genetics.

[11]  P. Coulombe,et al.  Cloning and Characterization of Multiple Human Genes and cDNAs Encoding Highly Related Type II Keratin 6 Isoforms (*) , 1995, The Journal of Biological Chemistry.

[12]  J. Rothnagel,et al.  Mutation of a type II keratin gene (K6a) in pachyonychia congenita , 1995, Nature Genetics.

[13]  E. Lane,et al.  Keratin 16 and keratin 17 mutations cause pachyonychia congenita , 1995, Nature Genetics.

[14]  E. Lane,et al.  Intermediate filaments in disease. , 1995, Current opinion in cell biology.

[15]  S. Bale,et al.  A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. , 1994, The Journal of investigative dermatology.

[16]  J. Lavergne,et al.  Human Gene Mutation , 1994 .

[17]  A. Ackerman,et al.  Neoplasms with sebaceous differentiation , 1994 .

[18]  K Weber,et al.  Intermediate filaments: structure, dynamics, function, and disease. , 1994, Annual review of biochemistry.

[19]  S. Bale,et al.  Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. , 1993, Biochemical and biophysical research communications.

[20]  D. Parry,et al.  Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. , 1993, Journal of molecular biology.

[21]  R. Leube,et al.  Characterization of the human gene encoding cytokeratin 17 and its expression pattern. , 1992, European journal of cell biology.

[22]  A. Letai,et al.  Do the ends justify the mean? Proline mutations at the ends of the keratin coiled-coil rod segment are more disruptive than internal mutations , 1992, The Journal of cell biology.

[23]  V. Krutovskikh,et al.  Patterns of expression of keratin 17 in human epithelia: dependency on cell position. , 1989, Journal of cell science.

[24]  R. D. Goldman,et al.  Intermediate filaments , 1984, The Journal of cell biology.